IMMUNOBIOLOGY OF INTERLUKIN-12
INTERLUKIN-12 的免疫生物学
基本信息
- 批准号:2761165
- 负责人:
- 金额:$ 31.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-05-01 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte CD44 molecule T lymphocyte biological signal transduction cell differentiation colony stimulating factor dendritic cells gene expression human subject interferon gamma interleukin 12 interleukin 13 interleukin 4 laboratory mouse leukocyte activation /transformation molecular cloning monocyte neoplastic cell protein biosynthesis tissue /cell culture tumor necrosis factor alpha
项目摘要
IL-12 is a central player in the regulation of inflammation and
immunity, serving as a bridge between innate resistance and adaptive
immunity. IL-12 production is important or essential in determining the
protective Th1 response against infectious pathogens and tumors, whereas
overproduction of IL-12 can result in a series of pathological
manifestations, including systemic inflammatory response syndrome,
organ-specific autoimmunity, sarcoidosis, vascular lesions, whereas
defective production can result in immunodeficiency and allergic
situations, including asthma. The study of the molecular mechanisms
involved in IL-12 production and function is thus important for the
understanding of the physiological role of IL-12 and for the planning
of the clinical use of the protein and its genes (in infectious
diseases, tumors, severe allergy, or as adjuvants in vaccination) or of
antagonists of its production and activity (in autoimmunity,
sarcoidosis, etc.). To this end, we propose to:
I. Analyze the molecular mechanisms of IL-12 p40 and p35 gene
expression;
II. Analyze the induction of IL-12 by CD44 signaling in phagocytic
cells and the effect of IL-4 and IL-13 on differentiation and production
of proinflammatory cytokines by human myelomonocytic and dendritic
cells;
III. Analyze the mechanisms of acute induction and priming for cytokine
production induced by IL-12 and costimulation.
IL-12是炎症调节的核心参与者,
免疫,作为先天抵抗力和适应性之间的桥梁
免疫力 IL-12的产生在确定免疫应答中是重要的或必需的。
保护性Th 1应答对抗感染性病原体和肿瘤,而
IL-12的过度产生可导致一系列病理性的
表现,包括全身炎症反应综合征,
器官特异性自身免疫、结节病、血管病变,而
生产缺陷可导致免疫缺陷和过敏
情况,包括哮喘。 分子机制的研究
参与IL-12的产生和功能,因此对于
了解IL-12的生理作用,
蛋白质及其基因的临床应用(在感染性
疾病,肿瘤,严重过敏,或作为疫苗接种的佐剂)或
其产生和活性的拮抗剂(在自身免疫中,
结节病等)。 为此,我们建议:
I. IL-12 p40和p35基因表达的分子机制分析
表情;
二. 分析吞噬细胞中CD 44信号转导对IL-12的诱导作用
IL-4和IL-13对细胞分化和分泌的影响
人骨髓单核细胞和树突状细胞的促炎细胞因子
细胞;
三. 细胞因子急性诱导和激发的机制分析
通过IL-12和共刺激诱导产生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GIORGIO TRINCHIERI其他文献
GIORGIO TRINCHIERI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GIORGIO TRINCHIERI', 18)}}的其他基金
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
粪便微生物群移植和免疫检查点阻断治疗实体瘤
- 批准号:
10393924 - 财政年份:2022
- 资助金额:
$ 31.55万 - 项目类别:
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
粪便微生物群移植和免疫检查点阻断治疗实体瘤
- 批准号:
10650717 - 财政年份:2022
- 资助金额:
$ 31.55万 - 项目类别:
相似海外基金
Inhibition of tumor growth, invasion, and metastasis by targeting CD44 molecule
靶向CD44分子抑制肿瘤生长、侵袭和转移
- 批准号:
13557094 - 财政年份:2001
- 资助金额:
$ 31.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
- 批准号:
2770673 - 财政年份:1997
- 资助金额:
$ 31.55万 - 项目类别:
CD44 MOLECULE VARIANT EXPRESSION IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中的 CD44 分子变异表达
- 批准号:
2471152 - 财政年份:1997
- 资助金额:
$ 31.55万 - 项目类别:
Study on CD44 molecule in follicular lymphoma
滤泡性淋巴瘤中CD44分子的研究
- 批准号:
07670232 - 财政年份:1995
- 资助金额:
$ 31.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




